Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
FranceIPO:
20 October 2023Website:
http://www.abivax.comNext earnings report:
09 September 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | Fri, 28 Jun 2024 13:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
ABVX Latest News
ABIVAX Société Anonyme (OTC:AAVXF) Q4 2023 Earnings Conference Call April 8, 2024 8:30 AM ET Company Participants Patrick Malloy - SVP, IR Marc de Garidel - CEO Sheldon Sloan - Chief Medical Officer Didier Scherrer - Chief Scientific Officer Conference Call Participants Thomas Smith - Leerink Partners Vikram Purohit - Morgan Stanley Julian Harrison - BTIG Operator Ladies and gentlemen, thank you for standing by. Welcome to ABIVAX Conference Call to discuss 2023 Financial Results and Business Update.
Both the calendar and the pipeline saw some movement this past week. Two large IPOs launched, one of which also priced, and two sizable deals submitted new filings. Eight IPOs submitted initial filings, led by three sizable names. Mach Natural Resources is currently the only IPO scheduled for the week ahead, although some small issuers may join the calendar late.
Abivax S.A. ABVX, -2.53% has increased the size of its global offering to 20.33 million shares from 18.68 million shares as part of its uplisting to the Nasdaq under the ticker symbol “ABVX” from Euronext Paris, according to a filing late Wednesday.
What type of business is Abivax SA American Depositary Shares?
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.
What sector is Abivax SA American Depositary Shares in?
Abivax SA American Depositary Shares is in the Healthcare sector
What industry is Abivax SA American Depositary Shares in?
Abivax SA American Depositary Shares is in the Biotechnology industry
What country is Abivax SA American Depositary Shares from?
Abivax SA American Depositary Shares is headquartered in France
When did Abivax SA American Depositary Shares go public?
Abivax SA American Depositary Shares initial public offering (IPO) was on 20 October 2023
What is Abivax SA American Depositary Shares website?
https://www.abivax.com
Is Abivax SA American Depositary Shares in the S&P 500?
No, Abivax SA American Depositary Shares is not included in the S&P 500 index
Is Abivax SA American Depositary Shares in the NASDAQ 100?
No, Abivax SA American Depositary Shares is not included in the NASDAQ 100 index
Is Abivax SA American Depositary Shares in the Dow Jones?
No, Abivax SA American Depositary Shares is not included in the Dow Jones index
When does Abivax SA American Depositary Shares report earnings?
The next expected earnings date for Abivax SA American Depositary Shares is 09 September 2024